Vinva Investment Management Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1968109 SYDNEY, C3

Position in VRTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$4,255,972

-$702,879 QoQ

Shares Held

9,531

-12.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Vinva Investment Management Ltd holds $66,411,479 across 13 Biotechnology names. VRTX ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	300,405	$28,274,118
2	ALNY	Alnylam Pharmaceuticals, Inc.	36,601	$12,110,172
3	REGN	Regeneron Pharmaceuticals, Inc.	14,862	$11,482,975
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	9,531	$4,255,972
5	EXEL	Exelixis, Inc.	49,204	$2,110,359
6	JAZZ	Jazz Pharmaceuticals plc	11,142	$2,106,395
7	HALO	Halozyme Therapeutics, Inc.	32,126	$2,076,303
8	ASND	Ascendis Pharma A/S	5,694	$1,302,388

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,255,972	9,531	-12.9%	Shares	Sole	2026-05-14
2025-12-31	$4,958,851	10,938	+26.7%	Shares	Sole	2026-02-17
2025-09-30	$3,381,811	8,635	-16.5%	Shares	Sole	2025-11-13
2025-06-30	$4,605,594	10,345	-21.3%	Shares	Sole	2025-08-13
2025-03-31	$6,369,080	13,137	+274.1%	Shares	Sole	2025-05-14
2024-12-31	$1,414,282	3,512	+43.8%	Shares	Sole	2025-02-11
2024-09-30	$1,136,190	2,443	-73.5%	Shares	Sole	2024-11-14
2024-06-30	$4,324,879	9,227	-4.9%	Shares	Sole	2024-08-13
2024-03-31	$4,057,205	9,706	+7.8%	Shares	Sole	2024-05-13
2023-12-31	$3,663,230	9,003	+12.6%	Shares	Sole	2024-02-13
2023-09-30	$2,780,876	7,997	+1.5%	Shares	Sole	2023-11-13
2023-06-30	$2,771,643	7,876	-10.1%	Shares	Sole	2023-08-14
2023-03-31	$2,759,067	8,757	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.